CHORIONIC GONADOTROPIN (CHORIONIC GONADOTROPIN, HUMAN)
- Cryptorchidism
- Hypogonadotropic hypogonadism
- Infertility associated with anovulation
- Pregnyl Intramuscular Solution
- Novarel Intramuscular Solution
- Chorionic Gonadotropin, Human Intramuscular Solution
- By Indication
10,000 unit intramuscular solution
- Dosage information is not available
10,000 unit intramuscular solution
- Dosage information is not available
5,000 unit intramuscular solution
- Dosage information is not available
, human 10,000 unit intramuscular solution
- Dosage information is not available
, human 5,000 unit intramuscular solution
- Dosage information is not available
Corpus luteum insufficiency syndrome
- Inject 1,500 unit by intramuscular route every other day
Hypogonadotropic hypogonadism
- Inject 1,000 unit by intramuscular route 3 times per week
- Inject 4,000 unit by intramuscular route 3 times per week
- Inject 4,000 unit by intramuscular route 3 times per week for 6 months
- Inject 4,000 unit by intramuscular route 3 times per week for 9 months
- Inject 2,000 unit by intramuscular route 3 times per week
- Inject 2,000 unit by intramuscular route 3 times per week for 3 months
Infertility associated with anovulation
- Inject 5,000 unit by intramuscular route x1 dose
- Inject 10,000 unit by intramuscular route x1 dose
- None
Contraindicated
- None
Severe
Moderate
- None
- Estrogen-dependent neoplasm
- Malignant tumor of testis
- Pituitary neoplasm
- Precocious puberty
- Pregnancy
- Prostatic carcinoma
Contraindicated
- Ovarian hyperstimulation syndrome
- Thromboembolic disorder
Severe
Moderate
- Edema
CHORIONIC GONADOTROPIN (CHORIONIC GONADOTROPIN, HUMAN)
- Cryptorchidism
- Hypogonadotropic hypogonadism
- Infertility associated with anovulation
- Ovarian enlargement
- Edema
More Frequent
Severe
Less Severe
- Precocious puberty
- Depression
- Fatigue
- Gynecomastia
- Headache disorder
- Injection site sequelae
- Irritability
- Nervousness
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute arterial thromboembolism
- Anaphylaxis
- Hypersensitivity drug reaction
- Ovarian hyperstimulation syndrome
- Ruptured ovarian cyst
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Chorionic Gonadotropin,Human (IM)
No safety and efficacy age < 4 years.
Discontinue if signs of precocious puberty occur.
- 1 Day – 4 Years
- No safety and efficacy age < 4 years.
- Discontinue if signs of precocious puberty occur.
- 4 Years – 11 Years
- No safety and efficacy age < 4 years.
- Discontinue if signs of precocious puberty occur.
Chorionic Gonadotropin (human)
- Severity Level:
X
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Hcg Alpha, Recombinant
Insufficient data available
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Cryptorchidism | |
Q53 | Undescended and ectopic testicle |
Q53.0 | Ectopic testis |
Q53.00 | Ectopic testis, unspecified |
Q53.01 | Ectopic testis, unilateral |
Q53.02 | Ectopic testes, bilateral |
Q53.1 | Undescended testicle, unilateral |
Q53.10 | Unspecified undescended testicle, unilateral |
Q53.11 | Abdominal testis, unilateral |
Q53.111 | Unilateral intraabdominal testis |
Q53.112 | Unilateral inguinal testis |
Q53.12 | Ectopic perineal testis, unilateral |
Q53.13 | Unilateral high scrotal testis |
Q53.2 | Undescended testicle, bilateral |
Q53.20 | Undescended testicle, unspecified, bilateral |
Q53.21 | Abdominal testis, bilateral |
Q53.211 | Bilateral intraabdominal testes |
Q53.212 | Bilateral inguinal testes |
Q53.22 | Ectopic perineal testis, bilateral |
Q53.23 | Bilateral high scrotal testes |
Q53.9 | Undescended testicle, unspecified |
R39.83 | Unilateral non-palpable testicle |
R39.84 | Bilateral non-palpable testicles |
Hypogonadotropic hypogonadism | |
E23.0 | Hypopituitarism |
Infertility associated with anovulation | |
N97.0 | Female infertility associated with anovulation |
0-9 | A-Z |
---|---|
E23.0 | Hypopituitarism |
N97.0 | Female infertility associated with anovulation |
Q53 | Undescended and ectopic testicle |
Q53.0 | Ectopic testis |
Q53.00 | Ectopic testis, unspecified |
Q53.01 | Ectopic testis, unilateral |
Q53.02 | Ectopic testes, bilateral |
Q53.1 | Undescended testicle, unilateral |
Q53.10 | Unspecified undescended testicle, unilateral |
Q53.11 | Abdominal testis, unilateral |
Q53.111 | Unilateral intraabdominal testis |
Q53.112 | Unilateral inguinal testis |
Q53.12 | Ectopic perineal testis, unilateral |
Q53.13 | Unilateral high scrotal testis |
Q53.2 | Undescended testicle, bilateral |
Q53.20 | Undescended testicle, unspecified, bilateral |
Q53.21 | Abdominal testis, bilateral |
Q53.211 | Bilateral intraabdominal testes |
Q53.212 | Bilateral inguinal testes |
Q53.22 | Ectopic perineal testis, bilateral |
Q53.23 | Bilateral high scrotal testes |
Q53.9 | Undescended testicle, unspecified |
R39.83 | Unilateral non-palpable testicle |
R39.84 | Bilateral non-palpable testicles |